LYCOS RETRIEVER 
Remicade: Arthritis Research
built 500 days ago
Remicade blocks tumor necrosis factor-alpha (TNF-alpha), a chemical "messenger" in the immune system that signals other cells to cause inflammation. There is too much TNF-alpha in the skin of people with psoriasis and the joints of people with certain types of arthritis, such as psoriatic arthritis.
Source:
By blocking the action of TNF-alpha, Remicade reduces the inflammation and its accompanying signs and symptoms. Remicade does not cure rheumatoid arthritis. However, studies have demonstrated that Remicade can inhibit the progress of joint destruction from rheumatoid arthritis.
Source:
DALLAS, Oct. 22 /PRNewswire/ — “Arthritis Without Pain” - the Miracle of TNF blockers, examines the science behind the TNF blockers Enbrel, Remicade and Humira, offers practical advice for their use and explores the real-life experience of patients who take them. Written by noted Dallas rheumatologist Scott J. Zashin, M.D. in collaboration with healthcare writer Laure Hesser, Arthritis Without Pain gives patients the knowledge to take charge of their arthritis, move past the pain, and get back to a more active life:
Source:
Centocor announced that the FDA had expanded its approval for Remicade to include psoriatic arthritis. The approval is for inhibiting the progression of structural damage along with improved physical function. About a million people in the U.S. suffer from psoriatic arthritis.
Source:
MORE ABOUT
Arthritis Research